21 results on '"Oral administration"'
Search Results
2. [Development of an ivermectin-containing syrup as an extemporaneous preparation for treatment of scabies in children]
- Author
-
Johannes, Wohlrab, L, Stadie, R H H, Neubert, and K, Bosse
- Subjects
Ivermectin ,Kindesalter ,Body-weight-adapted dosage ,Administration, Oral ,Orale Applikation ,Applikationshilfen ,Körpergewichtsadaptierte Dosierung ,Delivery aids ,Originalien ,Oral administration ,Scabies ,Child, Preschool ,Humans ,Off-label use ,Child ,Off-label-Anwendung ,Children ,Chromatography, High Pressure Liquid - Abstract
Oral ivermectin can be used to treat scabies. Evidence for safe and effective use in young children in individual treatment situations has been developed and published. In order to also ensure a body weight-adapted dosage for children, an ivermectin-containing syrup was developed as an extemporaneous preparation.Since ivermectin is not available as a pure substance for the formulation, tablets containing active ingredient were used as a basic material for development. The formulation was designed according to pharmaceutical, regulatory and use-oriented criteria. An HPLC (high-pressure liquid chromatography) method was developed and validated to demonstrate chemical stability. In order to facilitate the practical implementation, information on suitable packaging material and application aids was also developed and the formulation was evaluated.It has been demonstrated that the final formulation produced in the pharmacy was stable and can be stored for 3 weeks. No concerns were raised regarding the tolerability of the syrup formulation. The physicochemical properties and the taste of the formulation allow the intended use as a well-dosed syrup for children.The developed formulation meets the requirements of the Apothekenbetriebsordnung (Pharmacy Work Rules; Section 7 ApBetrO) and enables an exact, body weight-adapted dosage of oral ivermectin in young children. Studies on human pharmacokinetics or clinical studies to demonstrate tolerability and/or efficacy are not available for the formulation.HINTERGRUND: Zur Therapie der Skabies kann orales Ivermectin eingesetzt werden. Die Evidenz für einen sicheren und wirksamen Einsatz bei Kleinkindern im Einzelheilversuch ist erarbeitet worden und publiziert. Um eine körpergewichtsadaptierte Dosierung auch für Kinder zu gewährleisten, wurde ein Ivermectin-haltiger Saft als Magistralrezeptur entwickelt.Da Ivermectin nicht als Reinsubstanz für die Rezeptur zur Verfügung steht, wurden wirkstoffhaltige Tabletten als Ausgangsmaterial für die Entwicklung benutzt. Die Formulierung wurde entsprechend pharmazeutischer, regulatorischer und gebrauchsorientierter Kriterien konzipiert. Zum Nachweis der chemischen Stabilität wurde eine HPLC(Hochleistungsflüssigkeitschromatographie)-Methode erarbeitet und validiert. Um die praktische Umsetzung zu erleichtern, wurden zudem Angaben zu geeigneten Packmitteln und zu Applikationshilfen erarbeitet, und die Rezeptur wurde taxiert.Es konnte nachgewiesen werden, dass die finale Rezeptur stabil in der Apotheke hergestellt und über 3 Wochen gelagert werden kann. Es haben sich keine Bedenken bezüglich der Verträglichkeit des Rezeptursaftes ergeben. Die physikochemischen Eigenschaften und der Geschmack der Rezeptur ermöglichen den beabsichtigten Gebrauch als gut dosierbaren Saft für Kinder.Die entwickelte Rezeptur entspricht den Anforderungen der Apothekenbetriebsordnung (§ 7 ApBetrO) und ermöglicht eine exakte, körpergewichtsadaptierte Dosierung von oralem Ivermectin bei Kleinkindern. Untersuchungen zur Pharmakokinetik am Menschen bzw. klinische Studien zum Nachweis der Verträglichkeit und/oder Wirksamkeit liegen für die Rezeptur nicht vor.
- Published
- 2021
3. Opioide bei chronischen nicht-tumorbedingten Schmerzen - gibt es Unterschiede?
- Author
-
Lauche, R., Klose, P., Radbruch, L., Welsch, P., and Häuser, W.
- Abstract
Copyright of Der Schmerz is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2015
- Full Text
- View/download PDF
4. Retardiert freigesetztes Naloxon oral: Aufhebung der Obstipation durch orales Morphin ohne Beseitigung der Analgesie.
- Author
-
Jurna, I. and Baldauf, J.
- Abstract
Copyright of Der Schmerz is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 1993
- Full Text
- View/download PDF
5. [Development of an ivermectin-containing syrup as an extemporaneous preparation for treatment of scabies in children].
- Author
-
Wohlrab J, Stadie L, Neubert RHH, and Bosse K
- Subjects
- Administration, Oral, Child, Child, Preschool, Chromatography, High Pressure Liquid, Humans, Ivermectin therapeutic use, Scabies drug therapy
- Abstract
Background: Oral ivermectin can be used to treat scabies. Evidence for safe and effective use in young children in individual treatment situations has been developed and published. In order to also ensure a body weight-adapted dosage for children, an ivermectin-containing syrup was developed as an extemporaneous preparation., Materials and Methods: Since ivermectin is not available as a pure substance for the formulation, tablets containing active ingredient were used as a basic material for development. The formulation was designed according to pharmaceutical, regulatory and use-oriented criteria. An HPLC (high-pressure liquid chromatography) method was developed and validated to demonstrate chemical stability. In order to facilitate the practical implementation, information on suitable packaging material and application aids was also developed and the formulation was evaluated., Results: It has been demonstrated that the final formulation produced in the pharmacy was stable and can be stored for 3 weeks. No concerns were raised regarding the tolerability of the syrup formulation. The physicochemical properties and the taste of the formulation allow the intended use as a well-dosed syrup for children., Conclusion: The developed formulation meets the requirements of the Apothekenbetriebsordnung (Pharmacy Work Rules; Section 7 ApBetrO) and enables an exact, body weight-adapted dosage of oral ivermectin in young children. Studies on human pharmacokinetics or clinical studies to demonstrate tolerability and/or efficacy are not available for the formulation., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
6. Di-(2-propylheptyl) phthalate (DPHP) and its metabolites in blood of rats upon single oral administration of DPHP
- Author
-
Winfried Kessler, Dominik Klein, Johannes G. Filser, Rainer Otter, Brigitte Semder, J. Lichtmannegger, and Christian Pütz
- Subjects
0301 basic medicine ,Male ,Glucuronidation ,Phthalic Acids ,Administration, Oral ,010501 environmental sciences ,Pharmacology ,Toxicology ,01 natural sciences ,03 medical and health sciences ,chemistry.chemical_compound ,Oral administration ,Animals ,Rats, Wistar ,0105 earth and related environmental sciences ,Chemistry ,Di-(2-propylheptyl) Phthalate ,Blood ,Metabolites ,Oral Treatment ,Rat ,Phthalate ,General Medicine ,Bioavailability ,Rats ,030104 developmental biology ,Endocrine disruptor ,DPHP ,Toxicity ,Environmental Pollutants ,Toxicant - Abstract
Di-(2-propylheptyl) phthalate (DPHP) does not act as a reproductive toxicant or endocrine disruptor in contrast to other phthalates. Considering adverse effects of phthalates to be linked to their metabolism, it was the aim of the present study to investigate in the rat the blood burden of DPHP and its metabolites as a basis for understanding the toxicological behavior of DPHP. Rats were administered single oral doses of DPHP of 0.7 and 100mg/kg body weight. Concentration-time courses of DPHP and metabolites were monitored in blood. The areas under the concentration-time curves in blood (AUCs), normalized for the dose of DPHP, showed the following order: DPHP
- Published
- 2016
7. Computer findings using the Schilling test as an example
- Author
-
Vogel, H
- Published
- 1974
8. Wirkung von Milch und unterschiedlich zusammengesetzten Diättränken auf den intraluminalen pH-Wert des Labmagens sowie den systemischen Säuren-Basen- Status beim Kalb
- Author
-
Reinhold, Sabine
- Subjects
fluid therapy ,acid base equilibrium ,oral administration ,electrolytes ,rehydration ,calves ,abomasum - Abstract
Das Ziel der vorliegenden Arbeit war es, den Einfluss der oralen Zufuhr von Milch und unterschiedlich zusammengesetzten Elektrolyttränken auf den intraluminalen pH-Wert und der Elektrolytkonzentrationen im Labmagen zu untersuchen. Gleichzeitig sollten die Auswirkungen der verabreichten Diättränken auf die Parameter des systemischen Säuren-Basen-Status (SBS) im Blut ermittelt werden. Dazu wurde bei acht Kälbern im Alter von 19-38 Tagen eine Plastkanüle in den Labmagen operativ eingesetzt. Nach der Tränkung der Kälber mit Milch bzw. Elektrolyttränke wurden in den über die Kanüle entnommenen Labmageningesta der intraluminale pH-Wert, die Fläche unter der pH-Wertkurve (AUC) sowie die [SID3] bestimmt. Zur Beurteilung des systemischen SBS wurden unmittelbar vor jeder Tränkung und 2 h postprandial (pp) im arteriellen sowie venösen Blut die traditionellen Henderson-Hasselbalch- Parameter und die Variablen des aktuelleren Stewart-Modells erfasst. Im Anschluss an die Milchfütterung stieg der intraabomasale pH-Wert von 2,00 ± 0,44 (nüchtern) innerhalb von 30 min auf Werte bis 4,70 ± 0,41 an und sank innerhalb von 4 h postprandial kontinuierlich wieder auf pH=2,43 ± 0,37 ab. Die Fläche unter der pH-Wertkurve (AUC) für die Milchtränke betrug 912 ± 75. Die in Milch zubereiteten bikarbonatfreien Diättränken A und B führten nach ihrer Verabreichung an die Kälber zu signifikant basischeren Auslenkungen des pH-Wertes in den Labmageningesta. Dabei wurde bei Diättränke A ein pH-Anstieg von 1,93 ± 0,22 auf 5,64 ± 0,23 festgestellt (AUC=1166 ± 17), die Diättränke B verursachte nach ihrer Fütterung eine maximale pH-Auslenkung von 2,12 ± 0,57 (nüchtern) auf 5,34 ± 0,31 (AUC=1108 ± 89). Die in Wasser hergestellten bikarbonathaltigen Diättränken führten postprandial zu den transient stärksten Anstiegen des Labmagen-pH auf Werte bis 6,58 ± 0,30 (Tränke C), 6,80 ± 0,30 (Tränke D) und 6,71 ± 0,17 (Tränke E). Auch das Gemisch aus gleichen Teilen Milch und Diättränke C bzw. D verursachte gegenüber der Milchtränke transient höhere pH-Auslenkungen auf 6,22 ± 0,19 (C-1) und 6,22 ± 0,29 (D-1). Die AUC- Werte unterschieden sich mit 1118 ± 45 (Tränke C), 1159 ± 120 (Tränke D), 1117 ± 90 (Tränke E) sowie 1127 ± 45 (Tränke C-1) und 1062 ± 138 (Tränke D-1) signifikant von den Befunden nach Milchtränke, jedoch nicht von den Resultaten nach Verabreichung der bikarbonatfreien Diättränken. Im Nüchternzustand der Kälber wies der stark saure Labmageninhalt mit -61 bzw. -68 mmol/l negative, d. h. saure Werte für [SID3] auf. Nach der Milchtränke verringerten sich die negativen Befunde im Zeitraum von 1-2 Stunden in Richtung Null. Der Zusatz einer Elektrolyttränke ohne Bikarbonat (Tränke B) zur Milch führte nach der Tränkung zur Zunahme der [SID3] in den Labmageningesta bis in den positiven Bereich. Diese [SID3]-Befunde sind beachtenswert, da bisher keine vergleichbaren Ergebnisse in der Literatur vorliegen. Systemisch betrachtet waren zum Zeitpunkt 2 h postprandial nach der Verabreichung der verschiedenen Tränken geringe, teilweise signifikante basische Reaktionen im arteriellen und gleichermaßen im venösen Blut der Kälber nachweisbar. Für die Befunde des PCO2 ergaben sich keine von den unterschiedlichen Fütterungen abhängigen Veränderungen. Zusammen mit dem Anstieg der Henderson-Hasselbalch-Parameter pH, [HCO3-] und [BE] kam es auch zu nachweisbaren, teilweise signifikant angestiegenen Werten für die Stewart-Variable [SID3] (bei allen Elektrolyttränken) und zu einem verringerten [Atot] (bei Diättränken B, D, E, C-1 und D-1) im Blut der Kälber. Die zeitgleich zwar gering, oft jedoch signifikant aufgetretenen Anstiege für [HCO3-], [BE] und [SID3] sowie abfallende Befunde für [Atot] sind Ausdruck einer metabolisch bedingten alkalischen Veränderung im Blut. Die postprandial im Blut der Kälber festgestellte basische Flut war nach Gabe der bikarbonathaltigen Diättränken relativ am deutlichsten ausgeprägt. Die postprandialen intraabomasalen pH- Werte der in Wasser gelösten Diättränken kehren im Vergleich zur Fütterung von Milch schneller zu ihren Ausgangsbefunden zurück. Offenbar führt dieser zügige pH-Abfall zu einer verkürzten Transitzeit von Elektrolyttränken gegenüber der Milchtränke im Labmagen gesunder Kälber. Daher erreichen die Elektrolytlösungen, die in Wasser gelöst wurden, im Vergleich zur Milch zeitlich früher den Dünndarm als Ort ihrer Absorption., The aim of this study was to test the effect of suckling milk or different oral electrolyte solutions on abomasal luminal pH and the electrolyte concentration in abomasum of calves. Simultaneously the effect of the administered solutions on the acid-base-parameters of blood was determined. Eight healthy calves aged 19-38 days were surgically instrumented with an abomasal body cannula. Samples of abomasal content were obtained via the cannula before and after feeding. Abomasal luminal pH was monitored continuously every 15 minutes for four hours. The area under the pH/time-curve (AUC) and the strong ion difference (SID) were also determined. Pre-prandial and 2 hours postprandial, an arterial and venous blood samples were taken for the estimation of the acid-base-status using the Henderson-Hasselbalch- parameters and the Stewart-Variables. Milk feeding caused an increase of the abomasal luminal pre-prandial pH (mean ± SD) from a basal value of 2,00 ± 0,44 to a peak value of 4,70 ± 0,41 thirty minutes after feeding and a subsequent decrease to 2,43 ± 0,37 (four hours postprandial). The area under the pH/time- curve of milk feeding was 912 ± 75. Feeding electrolyte solutions A and B lacking bicarbonate mixed with milk resulted in a significantly higher alkaline pH of the abomasal fluid. Electrolyte solution A induced an increase of abomasal pH (mean ± SD) from 1,93 ± 0,22 to 5,64 ± 0,23 (AUC=1166 ± 17), OES B caused an increase of pH (mean ± SD) from 2,12 ± 0,57 (fasting) to 5,34 ± 0,31 (AUC=1108 ± 89). After feeding containing bicarbonate electrolyte solutions mixed with water, the abomasal luminal pH showed the largest transient pH-increase (mean ± SD) to 6,58 ± 0,30 (OES C), 6,80 ± 0,30 (OES D) and 6,71 ± 0,17 (OES E). In comparison with milk feeding the mixture of equal parts of milk and OES C and D caused a higher transient pH-value (mean ± SD) of 6,22 ± 0,19 (C-1) and 6,22 ± 0,29 (D-1). The AUC-Values of 1118 ± 45 (OES C), 1159 ± 120 (OES D), 1117 ± 90 (OES E) as well as 1127 ± 45 (OES C-1) and 1062 ± 138 (OES D-1) differed significantly from milk. There were no significant differences between OES with or without bicarbonate. Strong acid abomasal content in fasting calves has [SID3] acid values of -61 and -68 mmol/l. After ingestion milk the low [SID3]-values decreased towards 0 over 1-2 hours. Milk with oral electrolyte solution without bicarbonate induced an increase of the abomasal luminal [SID3] into the positive range. Comparable values in the literature are lacking. Both milk and electrolyte solution caused a partially significant alkaline reaction in arterial and venous blood samples of calves. PCO2 did not change. In conjunction with the increase of Henderson-Hasselbalch-parameters, pH, [HCO3-] and [BE] there was partially significant evidence for increased values of the Stewart-Variable [SID3] (all OES) as well as decreased [Atot] (OES B, D, E, C-1 and D-1) in blood samples of calves. The simultaneous increase of [HCO3-], [BE] and [SID3] and the decrease of [Atot] were small but significant. These alkaline reactions in blood were caused by the alkaline metabolic changes. The postprandial alkaline tide in venous and arterial blood of calves was significantly higher in the group fed electrolyte solution containing bicarbonate. The postprandial abomasal luminal pH-values measured after feeding electrolyte solution mixed in water, returned faster to their basic pH-values compared to milk-feeding. This efficient decrease of pH induced a shorter transit time of electrolyte solution in abomasum of calves than milk feeding. Oral electrolyte solution mixed in water reach the small intestine, the place for absorption, earlier than feeding milk.
- Published
- 2008
9. Influencing the retention of radiostrontium by means of chemical radioprotectors in irradiated rats
- Author
-
Feher, I
- Published
- 1974
10. Clinical experiments on the pharmacokinetics of propiramfumarate-$sup 14$C
- Published
- 1974
11. The effect of cadmium application on the chicken. P. 2. The distribution of cadmium in the organism
- Author
-
Suelz, M
- Published
- 1974
12. Dose-time effects of competitive displacement of radiopertechnetate by sodium perchlorate following oral and intravenous application
- Author
-
Schmitt, G
- Published
- 1975
13. Clinical investigation of the kinetics of radioiodine and the biological half-life of orally administered $sup 131$I
- Author
-
Hebestreit, H
- Published
- 1973
14. Radiation-protective properties and the mode of action of Fenchlorfos
- Author
-
Szymanski, A
- Published
- 1973
15. Therapy of radiation damage in mice with O-($beta$-hydroxyethyl)-rutoside
- Author
-
Brueckner, V
- Published
- 1973
16. Mode of excretion and the metabolic behavior of / sup 99m/Tc-pertechnetate in the human body
- Author
-
Herzfeld, U
- Published
- 1973
17. [Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma]
- Author
-
U. Harnest, R. Sakalauskas, N. Vetter, V. W. Steinijans, H. Steffen, Asaf Keller, S. Leichtl, F. Rathgeb, P. Magyar, and D. Ukena
- Subjects
Male ,Pulmonary and Respiratory Medicine ,Adult ,Adolescent ,medicine.drug_class ,Anti-Inflammatory Agents ,Statistics, Nonparametric ,Drug Administration Schedule ,Double-Blind Method ,Theophylline ,Oral administration ,Bronchodilator ,Forced Expiratory Volume ,Administration, Inhalation ,Medicine ,Humans ,Asthma ,Aged ,Inhalation ,Dose-Response Relationship, Drug ,business.industry ,Beclomethasone ,Beclometasone dipropionate ,Middle Aged ,Prognosis ,medicine.disease ,Bronchodilator Agents ,Respiratory Function Tests ,Europe ,Treatment Outcome ,Anesthesia ,Salbutamol ,Corticosteroid ,Female ,Drug Therapy, Combination ,business ,medicine.drug - Abstract
The anti-asthmatic effects of theophylline may supplement those of inhaled steroids in asthma. The aim of the present trial was to study how the addition of theophylline compares to doubling the dose of inhaled steroid in asthmatics who remain symptomatic on beclomethasone dipropionate (BDP) 400 microg x day(-1). The trial was designed as a randomized, double-blind, parallel-group study in several European countries. Sixty nine patients were treated for 6 weeks with theophylline plus BDP 400 microg x day(-1), compared to 64 patients treated with BDP 800 micro x day(-1). The mean+/-SD serum theophylline concentration was 10.1+/-4.2 mg x L(-1). Lung function measurements were made throughout the study and patients kept daily records of peak expiratory flow (PEF), symptoms and salbutamol usage. Forced expiratory volume in one second and PEF at week 6 were significantly increased by both treatments (p
- Published
- 1998
18. Oral appliziertes Prostaglandin E2 zur Prophylaxe gastroduodenaler Streßläsionen beim Schwein
- Author
-
Germann, G. and Hottenrott, C.
- Published
- 1981
- Full Text
- View/download PDF
19. [Stress and aging]
- Author
-
Hans Selye
- Subjects
Pregnenolone Carbonitrile ,medicine.medical_specialty ,Aging ,Canada ,Necrosis ,Anabolism ,Myocardial Infarction ,Disease ,Potassium Chloride ,Lesion ,Anabolic Agents ,Progeria ,Chlorides ,Stress, Physiological ,Oral administration ,Calcium Metabolism Disorders ,Internal medicine ,Adaptation, Psychological ,medicine ,Animals ,Humans ,Magnesium ,History of Medicine ,Calcium metabolism ,business.industry ,Calciphylaxis ,Sodium ,Adaptation, Physiological ,Rats ,Disease Models, Animal ,Endocrinology ,Austria ,Dihydrotachysterol ,Female ,Steroids ,Geriatrics and Gerontology ,medicine.symptom ,business ,General Adaptation Syndrome ,Hormone ,medicine.drug - Abstract
The experimental “aging” exemplified in the progeria-like syndrome (induced by dihydrotachysterol, DHT, in rats) is not the cause but the consequence of disturbed calcium metabolism. Certain anabolic steroids can prevent the loss of body weight (protein) and the abnormal tissue calcification. Moreover, steroidal substances designated “catatoxic” have been found to play a role in adaptive reactions, particularly the maintenance of resistance to stress. Thus the anti-DHT effect of the steroids is not due to their antimineralocorticoid or anabolic action, but to their catatoxic (antitoxic) potency. An experimental biochemical disease model—the “Electrolyte-Steroid-Cardiopathy with Necrosis” (ESCN)—was developed to demonstrate a typical pluricausal disease in which several factors operate conjointly to produce a lesion. Glucomineralo-corticoids plus sodium salts were outstanding factors in the production of cardiac necrosis. This experimental necrosis could be prevented by KCl or MgCl2. However, oral administration of KCl has many drawbacks for the prophylaxis or treatment of myocardial infarction; more convenient and lasting methods of providing potassium are needed. Certain catatoxic steroids also were found to be efficacious in preventing ESCN. These data may eventually help in finding ways to combat spontaneous aging. Aging has no specific cause. Body hormones and numerous other factors play decisive roles.
- Published
- 1977
20. Intravenous glucose tolerance test in hypophysectomized rats
- Author
-
Robert O. Scow and Sidney S. Chernick
- Subjects
Glucose tolerance test ,medicine.medical_specialty ,medicine.diagnostic_test ,Intravenous Glucose Tolerance ,business.industry ,Blood sugar ,Glucose Tolerance Test ,Rats ,Endocrinology ,Blood chemistry ,Phenylbutazone ,Oral administration ,Physiology (medical) ,Internal medicine ,medicine ,Animals ,Intravenous Glucose Tolerance Test ,business ,Hypophysectomy - Abstract
Intravenous glucose tolerance tests were performed on normal and hypophysectomized rats that had been allowed to eat at will or were fed a constant amount by tube. The rates of removal of excess blood glucose ( k) were calculated. The k values for unoperated rats were the same regardless of the means of administration of food. The rate of removal of excess glucose was decreased in ad libitum-fed but not in tube-fed hypophysectomized rats. In the operated animals the value of k was not constant; it increased with time after administration of glucose load. Increasing the duration of fasting of operated tube-fed rats decreased the k; prior oral administration of glucose to hypophysectomized rats fed ad libitum increased the k. The lability of the intravenous glucose tolerance test in hypophysectomized rats is stressed.
- Published
- 1958
21. [Influence of galactose on insulin secretion in humans]
- Author
-
F. Melani, K. Rommel, K. Grimmel, and H. Burkhardt
- Subjects
Blood Glucose ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Blood sugar ,chemistry.chemical_compound ,Islets of Langerhans ,Blood serum ,Oral administration ,Internal medicine ,Insulin receptor substrate ,Insulin Secretion ,Internal Medicine ,medicine ,Humans ,Insulin ,business.industry ,Galactose ,Stimulation, Chemical ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Blood chemistry ,Pancreas ,business ,Secretory Rate - Abstract
Galaktose ruft sowohl nach oraler als auch nach intravenoser Gabe eine Insulinsekretion hervor. Die Insulinsekretion wird durch die im Galaktose-katabolismus entstandene Glucose ausgelost.
- Published
- 1969
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.